MIR6513: A Promising Drug Target and Biomarker (G102465256)
MIR6513: A Promising Drug Target and Biomarker
MIR6513 (humanities-specific microRNA-6513) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and specificity make it an attractive target for researchers to study and develop new treatments.
MIR6513 is a microRNA, which is a small non-coding RNA molecule that plays a crucial role in gene expression. MicroRNAs are made up of a sequence of RNA nucleotides that are typically between 20 and 220 base pairs in length. They are involved in regulating gene expression by binding to specific target mRNAs and causing them to be translated into proteins.
MIR6513 is different from other microRNAs because of its specificity. It is only expressed in the brain and nervous system, and its levels are highly regulated in these tissues. This specificity makes it an attractive target for studying the function of microRNAs in these regions and for developing new treatments for neurological diseases.
MIR6513 has also been shown to play a role in several diseases, including cancer. Studies have shown that MIR6513 is downregulated in various types of cancer, and that increasing its levels can inhibit the growth of these tumors. This suggests that MIR6513 may be a useful biomarker for cancer and that targeting it may be a promising strategy for new treatments.
Another potential application of MIR6513 is its role as a drug target. The high specificity of MIR6513 makes it an attractive target for small molecule inhibitors. Studies have shown that MIR6513 is responsive to small molecules such as inhibitors, and that these inhibitors can effectively decrease its levels. This suggests that MIR6513 may be a valuable drug target for treating various diseases, including cancer.
In conclusion, MIR6513 is a unique and promising drug target and biomarker. Its specificity and regulation in the brain and nervous system make it an attractive target for researchers to study and develop new treatments for various diseases. Further studies are needed to fully understand the role of MIR6513 in these processes and to develop new treatments based on its properties.
Protein Name: MicroRNA 6513
More Common Targets
MIR6514 | MIR6515 | MIR6516 | MIR652 | MIR653 | MIR654 | MIR655 | MIR656 | MIR657 | MIR658 | MIR659 | MIR660 | MIR661 | MIR662 | MIR663A | MIR663AHG | MIR663B | MIR664A | MIR664B | MIR665 | MIR668 | MIR670 | MIR671 | MIR6715A | MIR6715B | MIR6716 | MIR6717 | MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787
